MACKAY SHIELDS LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKAY SHIELDS LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,938,000
-49.9%
40,200
-45.9%
0.01%
-48.1%
Q4 2020$3,865,000
+101.9%
74,300
+3.9%
0.03%
+107.7%
Q3 2020$1,914,000
+67.0%
71,500
+21.6%
0.01%
+44.4%
Q2 2020$1,146,000
+404.8%
58,800
+44.8%
0.01%
+350.0%
Q3 2018$227,000
-38.8%
40,600
+44.0%
0.00%
-33.3%
Q2 2018$371,00028,2000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders